Orebatinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Orebatinib, covering 2024-08-29 to 2024-08-29. Get the full timeline:
Most recent: Clinical Trial Update: Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL [Phase 2]